References
- Wu O, Leng JH, Yang FF, Yang H-M, Zhang H, Li Z-F, Zhang X-Y, Yuan C-D, Li -J-J, Pan Q, et al. A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups[J]. Clin Exp Hypertens. 2018;40(1):16–21. doi:https://doi.org/10.1080/10641963.2017.1281940.
- Favero G, Stacchiotti A, Castrezzati S, Bonomini F, Albanese M, Rezzani R, Rodella LF. Melatonin reduces obesity and restores adipokine patterns and metabolism in obese (ob/ob) mice[J]. Nutr Res. 2015;35(10):891–900. doi:https://doi.org/10.1016/j.nutres.2015.07.001.
- Muoio DM, Newgard CB. Metabolism: a is for adipokine[J]. Nature. 2005;436(7049):337–38. doi:https://doi.org/10.1038/436337a.
- Takahashi H, Alves CRR, Stanford KI, Middelbeek RJW, Nigro P, Ryan RE, Xue R, Sakaguchi M, Lynes MD, So K, et al. Tgf-beta2 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism[J]. Nat Metab. 2019;1(2):291–303. doi:https://doi.org/10.1038/s42255-018-0030-7.
- Wang ZV, Scherer PE. Adiponectin, the past two decades[J]. J Mol Cell Biol. 2016;8(2):93–100. doi:https://doi.org/10.1093/jmcb/mjw011.
- Choi HM, Doss HM, Kim KS. Multifaceted physiological roles of adiponectin in inflammation and diseases[J]. Int J Mol Sci. 2020;21(4).
- Waragai M, Ho G, Takamatsu Y, Wada R, Sugama S, Takenouchi T, Masliah E, Hashimoto M. Adiponectin paradox in Alzheimer’s disease; relevance to amyloidogenic evolvability?[J]. Front Endocrinol (Lausanne). 2020;11:108.
- Dieplinger B, Poelz W, Haltmayer M, Mueller T. Association of adiponectin and amino terminal probnp in peripheral arterial disease[J]. Clin Chim Acta. 2007;377(1–2):192–97. doi:https://doi.org/10.1016/j.cca.2006.09.022.
- Diez JJ, Iglesias P. The role of the novel adipocyte-derived protein adiponectin in human disease: an update[J]. Mini Rev Med Chem. 2010;10(9):856–69. doi:https://doi.org/10.2174/138955710791608325.
- Yu H, Chhabra KH, Thompson Z, Jones GL, Kiran S, Shangguan G, Low MJ. Hypothalamic pomc deficiency increases circulating adiponectin despite obesity[J]. Mol Metab. 2020;35:100957.
- Acquarone E, Monacelli F, Borghi R, Nencioni A, Odetti P. Resistin: a reappraisal[J]. Mech Ageing Dev. 2019;178:46–63.
- Steppan CM, Lazar MA. The current biology of resistin[J]. J Intern Med. 2004;255(4):439–47. doi:https://doi.org/10.1111/j.1365-2796.2004.01306.x.
- Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR, Willson TM, Kliewer SA, Hotamisligil GS, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists[J]. J Biol Chem. 2001;276(28):25651–53. doi:https://doi.org/10.1074/jbc.C100189200.
- Mostafazadeh M, Haiaty S, Rastqar A, Keshvari M. Correlation between resistin level and metabolic syndrome component: a review[J]. Horm Metab Res. 2018;50(7):521–36. doi:https://doi.org/10.1055/a-0637-1975.
- McTernan PG, Kusminski CM, Kumar S. Resistin[J]. Curr Opin Lipidol. 2006;17(2):170–75. doi:https://doi.org/10.1097/01.mol.0000217899.59820.9a.
- Rodriguez-Lopez CP, Gonzalez-Torres MC, Cruz-Bautista I, et al Visceral obesity, skeletal muscle mass and resistin in metabolic syndrome development[J]. Nutr Hosp. 2019;36:43–50.
- Lau CH, Muniandy S. Novel adiponectin-resistin (ar) and insulin resistance (irar) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study[J]. Cardiovasc Diabetol. 2011;10:8. doi:https://doi.org/10.1186/1475-2840-10-8.
- Meschi E, Delanoue R. Adipokine and fat body in flies: connecting organs[J]. Mol Cell Endocrinol. 2021;533:111339. doi:https://doi.org/10.1016/j.mce.2021.111339.
- Shafer-Eggleton J, Adams-Huet B, Jialal I. Chemerin ratios to HDL-cholesterol and adiponectin as biomarkers of metabolic syndrome[J]. Endocr Res. 2020;45(4):241–45. doi:https://doi.org/10.1080/07435800.2020.1811724.
- Wu O, Leng JH, Yang FF, Zhang H, Zhang XY, Li JJ, Lu X. The paradox of the role of resistin in early-onset obesity hypertension: a comparative study among four Chinese adult subgroups[J]. Clin Exp Hypertens. 2021;43(5):385–91. doi:https://doi.org/10.1080/10641963.2021.1883049.
- Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the jnc 7 report[J]. JAMA. 2003;289(19):2560–72. doi:https://doi.org/10.1001/jama.289.19.2560.
- Wang SK, Ma W, Wang S, Yi X-R, Jia H-Y, Xue F. Obesity and its relationship with hypertension among adults 50 years and older in Jinan, China[J]. PLoS One. 2014;9(12):e114424. doi:https://doi.org/10.1371/journal.pone.0114424.
- Arimura ST, Moura BM, Pimentel GD, et al Waist circumference is better associated with high density lipoprotein (HDL-c) than with body mass index (BMI) in adults with metabolic syndrome[J]. Nutr Hosp. 2011;26:1328–32.
- Chen C, F C L; Department of Disease Control Ministry of Health P R C. The guidelines for prevention and control of overweight and obesity in Chinese adults[J]. Biomed Environ Sci. 2004;17(Suppl):1–36.
- Apovian CM. Obesity: definition, comorbidities, causes, and burden[J]. Am J Manag Care. 2016;22(7 Suppl):s176–185.
- Lopatynski J, Mardarowicz G, Szczesniak G. A comparative evaluation of waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index as indicators of impaired glucose tolerance and as risk factors for type-2 diabetes mellitus[J]. Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):413–19.
- Kundu S, Aulchenko YS, van Duijn CM, Janssens ACJW. Predictabel: an r package for the assessment of risk prediction models[J]. Eur J Epidemiol. 2011;26(4):261–64. doi:https://doi.org/10.1007/s10654-011-9567-4.
- Liu W, Zhou X, Li Y, Zhang S, Cai X, Zhang R, Gong S, Han X, Ji L. Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: a population-based study[J]. Medicine (Baltimore). 2020;99(6):e19052. doi:https://doi.org/10.1097/MD.0000000000019052.
- Stumvoll M, Haring H. Resistin and adiponectin–of mice and men[J]. Obes Res. 2002;10(11):1197–99. doi:https://doi.org/10.1038/oby.2002.162.
- Sarray S, Madan S, Saleh LR, Mahmoud N, Almawi WY. Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome. Fertil Steril. 2015;104(2):460–66. doi:https://doi.org/10.1016/j.fertnstert.2015.05.007.
- Rak A, Mellouk N, Froment P, Dupont J. Adiponectin and resistin: potential metabolic signals affecting hypothalamo-pituitary gonadal axis in females and males of different species[J]. Reproduction. 2017;153(6):R215–R226. doi:https://doi.org/10.1530/REP-17-0002.
- Stadler JT, Marsche G. Obesity-related changes in high-density lipoprotein metabolism and function[J]. Int J Mol Sci. 2020;21(23):8985. doi:https://doi.org/10.3390/ijms21238985.
- Hall JE, do Carmo JM, Da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms[J]. Circ Res. 2015;116(6):991–1006. doi:https://doi.org/10.1161/CIRCRESAHA.116.305697.